Clinical Trials Directory

Trials / Completed

CompletedNCT03536091

Magnification Endoscopy and Electronic Chromoendoscopy in Patients With Inflammatory Bowel Disease

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
University of Erlangen-Nürnberg Medical School · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

In this study the investigators aim to evaluate the ability of i-scan OE together with magnification endoscopy to detect and assess microscopic inflammation in patients with inflammator bowel diseases (IBD).

Detailed description

In this study the investigators aim to evaluate the ability of i-scan OE together with magnification endoscopy to detect and assess microscopic inflammation in patients with inflammator bowel diseases. For this purpose, IBD patients will be prospectively enrolled and inflammatory changes will be assessed using optical magnification endoscopy in conjunction with optical chromoendoscopy. Endoscopic scoring of inflammatory changes in IBD patients will be done on a newly developed magnification score resulting as a consensus from experts in optical diagnosis and endoscopy in IBD patients. Results will be correlated against histopathology.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMagnification endoscopyAll IBD patients will undergo magnification endoscopy with 136-fold optical magnification in conjunction with optical chromoendoscopy

Timeline

Start date
2017-03-01
Primary completion
2018-06-01
Completion
2018-07-01
First posted
2018-05-24
Last updated
2019-09-26

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03536091. Inclusion in this directory is not an endorsement.

Magnification Endoscopy and Electronic Chromoendoscopy in Patients With Inflammatory Bowel Disease (NCT03536091) · Clinical Trials Directory